Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on cytokine messenger RNA expression following viral challenge in calves

American Journal of Veterinary Research

Volumn 65, Issue 6, 2004, Pages 725-733

  Miao, Congrong ^a,c   Woolums, Amelia R ^a   Zarlenga, Dante S ^b   Brown, Corrie C ^a   Brown Jr , James C ^a,d   Williams, Shamita M ^a   Scott, Melissa A ^a,e  

^a UNIVERSITY OF GEORGIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; LIVE VACCINE; MESSENGER RNA; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TISSUE CULTURE MEDIUM; TUMOR NECROSIS FACTOR ALPHA;

ADENOID; ARTICLE; BRONCHUS; CATTLE; CLINICAL FEATURE; CONTROLLED STUDY; HELPER CELL; LUNG LAVAGE; LYMPH NODE; NONHUMAN; PROTEIN EXPRESSION; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRACHEA;

ADMINISTRATION, INTRANASAL; ANIMALS; BRONCHOALVEOLAR LAVAGE; CATTLE; CATTLE DISEASES; CYTOKINES; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; INTERFERON TYPE II; INTERLEUKIN-4; LUNG; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; BRONCHUS; PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS;

EID: 3042581229     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.725     Document Type: Article

References (39)

1. Heilman CA. Respiratory syncytial and parainfluenza viruses. J Infect Dis 1990;161:402-406.
2. Van der poel WHM, Brand A, Kramps JA, et al. Respiratory syncytial virus infections in human beings and in cattle. J Infect 1994; 29:215-228.
3. Larsen LE. Bovine respiratory, syncytial virus: a review. Acta Vet Scand 2000;41:1-24.
4. Varga SM, Braciale TJ. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology 2000;295:203-207.
5. Gaddum RM, Cook RS, Thomas LH, et al. Primary cytotoxic T cell responses to bovine respiratory syncytial virus in calves. Immunology 1996;88:421-427.
6. van Schaik SM, Welliver RC, Kimpen JLL. Novel pathways in the pathogenesis of respiratory syncytial virus disease. Pediatr Pulmonol 2000;30:131-138.
7. Gershwin LJ, Gunther RA, Anderson ML, et al. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-γ expression in pulmonary lymph of experimentally infected calves. Am J Vet Res 2000;61:291-298.
8. Brandenburg AH, Kleinjan A, van het Land B, et al. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000; 62:267-277.
9. van Schaik SM, Obot N, Enhorning G, et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med Virol 2000;62:257-266.
10. Woolums AR, Singer RS, Boyle GA, et al. Interferon gamma production during bovine respiratory syncytial virus infection is diminished in calves vaccinated with formalin-inactivated BRSV. Vaccine 1999;17:1293-1297.
11. West K, Petrie L, Konoby C, et al. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves. Vaccine 2000;18:907-919.
12. Kalina WV, Woolums AR, Berghaus RD, et al. Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 2004;22:1465-1474.
13. Gershwin LJ, Schelegle ES, Gunther RA, et al. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 1998;16:1225-1236.
14. Schreiber P, Matheise JP, Dessy F, et al. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian White Blue calves previously vaccinated with an inactivated BRSV vaccine. Zentralbl Veterinarmed [B] 2000;47:535-550.
15. Kimman TG, Sol J, Westenbrink F, et al. A severe outbreak of respiratory tract disease associated with respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet Q 1989;11:250-253.
16. Kimman TG, Westenbrink F, Straver PJ. Priming for local and systemic antibody memory responses to BRSV: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol 1989;22:145-160.
17. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5:171-177.
18. Kumkel SL, Strieter RM, Chensue SW, et al. Tumor necrosis factor-alpha, interleukin 8 and chemotactic cytokines. In: Melli M, Parente L, eds. Cytokines and lipocortins in inflammation and differentiation: Proceedings. New York: Wiley-Liss, 1990;433-444.
19. Viltek J, Lee TH. Tumor necrosis factor: new insights into molecular mechanisms of its multiple actions. J Biol Chem 1991; 266:7313-7316.
20. Hayes PJ, Scott R, Wheeler J. In vivo production of tumour necrosis factor-alpha and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virus. J Med Virol 1994;42:323-329.
21. Røntved CM, Tjørnehøj K, Viuff B, et al. Increased pulmonary secretion of tumor necrosis factor-α in calves experimentally infected with bovine respiratory syncytial virus. Vet Immunol Immunopathol 2000;76:199-214.
22. Woolums AR, Brown C, Brown JC Jr, et al. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves. Am J Vet Res 2004;65:363-372.
23. Woolums AR, Anderson ML, Gunther RA, et al. Evaluation of severe disease induced by aerosol inoculation of calves with bovine respiratory syncytial virus. Am J Vet Res 1999;60:473-480.
24. Collie DD. Pulmonary function changes and clinical findings associated with chronic respiratory disease in calves. Br Vet J 1992; 148:33-40.
25. Zarlenga DS, Canals A, Gasbarre L. Method for constructing internal standard for use in competitive PCR. Biotechniques 1995; 19:324-326.
26. Canals A, Zarlenga DS, Gasbarre LC. Quantification of bovine cytokine gene expression with Rnase protection assay and competitive RT-PCR. Vet Immunol Immunopathol 1996;54:349-350.
27. Canals A, Zarlenga DS, Almeria S, et al. Cytokine profile induced by a primary infection with Ostertagia ostertagi in cattle. Vet Immunol Immunpathol 1997;58:63-75.
28. Matsuda K, Tsutsumi H, Okamoto Y, et al. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immunol 1995;2:322-324.
29. Cirino NM, Panuska JR, Villani A, et al. Restricted replication of respiratory syncytial virus in human alveolar macrophages. J Gen Virol 1993;74:1527-1537.
30. Merolla R, Rebert NA, Tsiviste PT, et al. Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta. Am J Respir Cell Mol Biol 1995;152:1358-1366.
31. Neuzil KM, Tang YW, Graham BS. Protective role of TNF-α in respiratory syncytial virus infection in vitro and in vivo. Am J Med Sci 1996;311:201-204.
32. Graham BS, Henderson GS, Tang YW, et al. Priming immunization determines T helper cytokme mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993; 51:2032-2040.
33. Tang YW, Neuzil KM, Fischert JE, et al. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus. Vaccine 1997;15:597-602.
34. Roman M, Calhoun WJ, Hiton KL, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-195.
35. Almeria S, Canals A, Zarlenga DS, et al. Quantification of cytokme gene expression in lamina propria lymphocytes of cattle following infection with Ostertagia ostertagi. J Parasitol 1997; 83:1051-1055.
36. Waldvogel AS, Hediger-Weithaler BM, Eicher R, et al. Interferon-gamma and interleukin-4 mRNA expression by peripheral blood mononuclear cells from pregnant and non-pregnant cattle seropositive for bovine viral diarrhea virus. Vet Immunol Immunopathol 2000;77:201-212.
37. Eeard F, Wild MT, Garcia-Sanz JA, et al. Switch of CD8 T cells to noncytolytic CD8-CD4-cells that make Th2 cytokines and help B cells. Science 1993;260:1802-1805.
38. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993;178:567-577.
39. Ferrick DA, Schrenzel MD, Mulvania T, et al. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2- stimulating pathogens by gamma delta T cells in vivo. Nature 1995;373:255-257.